Articles Related to NCCN
Overuse and Misuse of Adjuvant Chemotherapy for Stages I and II Non-Small Cell Lung Cancer Chemotherapy: Empirical Findings from a Privately Insured Population
Among persons with early stage non-small cell lung cancer (NSCLC) resected for cure, appropriate use of adjuvant chemotherapy is an important additional determinant of survival. Oncology quality improvement initiatives focus on reducing overuse, underuse, and misuse.
Editorial Board Members Related to NCCN
KELLI BULLARD DUNN
Professor
Department of Surgery
Roswell Park Cancer Institute
University of Louisville School of Medicine
United States
Department of Surgery
Roswell Park Cancer Institute
University of Louisville School of Medicine
United States